The European Commission has published Decision 2025/2371, which officially confirms that EUDAMED meets its functional requirements. In accordance with Article 123(d) of the MDR, EUDAMED will become mandatory six months after publication, i.e. from May 28, 2026. The system was originally supposed to be fully operational in the second quarter of 2024. Additionally, on January […]
The UDI module is the central component of EUDAMED. Manufacturers are required to input their products and relevant information into the database to enhance transparency for patients and ensure traceability. To ensure data quality and compliance, information must be entered accurately and in accordance with EUDAMED’s business rules. As a result, many manufacturers are seeking […]
Read More… from UDI Registration With Master Data Pre-Validation
Even with intensively tested medical devices, unknown side effects can occur among users. If such an incident does occur, it must be documented according to Article 80(2) of the Medical Device Regulation (MDR). The EUDAMED database is the contact point for this respective documentation. In addition, there is a reporting obligation for incidents that have […]
In the European Union, medicinal products and medical devices are only approved for the market if manufacturers can guarantee the safety of their products. If adverse events occur after the products have been placed on the market, the vigilance procedures of the respective industries take effect. This is because patient safety continues to be a […]
With a go-live date for the EUDAMED next year and a deadline for the Medical Devices Regulation (MDR) in the not-too-distant future, it is important to take care of your product data now. There are three ways to upload the data to EUDAMED: using an M2M interface, by manual entry, or via bulk upload of […]
Medical device manufacturers are required by the MDR/IVDR to monitor the safety of their products even after they have been approved and have entered the market. This process is called Post-Market Surveillance (PMS) or Post-Marketing Surveillance. Due to the considerable amount of work involved, it can be advantageous to outsource this process to other companies. […]
Many manufacturers ask themselves whether a clinical evaluation or clinical trial is necessary for their medical devices. The MDR requirements are quite extensive and specific. Various products previously categorized as equivalent under the MDD now belong to a different risk class and existing clinical data are often no longer accepted by notified bodies. The MDR […]
A custom-made device in MedTech is a product prescribed to a patient by an authorized person, such as a physician. This product, by prescription, is manufactured exclusively for the respective person. Mass products with adaptions adjusted to fit the user’s needs are not considered as custom-made devices. Custom-made devices were already part of the Medical […]
What requirements must a product fulfill before it can ultimately be sold in the EU? This question is answered in the second chapter of the Medical Device Regulation (MDR). It includes information on placing products on the market, commissioning, and the role of authorized representatives. The responsibility for this lies with manufacturers, importers, and distributors. […]
Read More… from MDR – Market Entry Consideration for MedTech Products
Medical devices play a crucial role in modern healthcare. Their regulation is essential to ensure safety and efficacy. In recent years, regulatory changes in this area had a significant impact on industry and patients. In particular, regulatory requirements and changes in and around the Medical Device Regulation (MDR) are compelling stakeholders to stay on top […]
Read More… from MedTech News 2022 – The Most Important Developments